Phoenix Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Phoenix Wealth Advisors's BMY Position: Q4 2021 in Review
Phoenix Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 1,475 shares — an estimated $87K sold.
Phoenix Wealth Advisors first reported a position in BMY in Q4 2020 and held it in 4 quarters. The position peaked at $102K in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- Phoenix Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
- Phoenix Wealth Advisors sold 1,475 Bristol-Myers Squibb shares in Q4 2021, an estimated $87K.
- Phoenix Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 4 quarters.
- Phoenix Wealth Advisors's Bristol-Myers Squibb position peaked at $102K in Q2 2021.
- 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on Phoenix Wealth Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.